KBW downgrades Allstate to Market Perform, cuts target to $242

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Keefe, Bruyette & Woods analyst Meyer Shields downgraded Allstate from Outperform to Market Perform and lowered the price target from $266 to $242, reflecting a revised outlook.

powered bylight_fuzz_icon
42490596

*this image is generated using AI for illustrative purposes only.

Keefe, Bruyette & Woods analyst Meyer Shields has downgraded Allstate from Outperform to Market Perform. The firm also reduced the price target for the stock to $242, down from the previous target of $266. The adjustment reflects a revised outlook on the insurance provider's performance.

The rating change moves Allstate out of the Outperform category, signaling a shift in expectations. The new price target of $242 represents a decrease from the earlier projection of $266. This decision was communicated in a recent analyst note.

Allstate is listed on the NYSE under the ticker symbol ALL. The downgrade and price target cut are the key actions taken by Keefe, Bruyette & Woods in this update.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific factors led to the revised outlook on Allstate's performance?

How might this downgrade influence other analysts' ratings on Allstate?

What impact could the price target cut have on Allstate's stock price in the short term?

like15
dislike